| | | | | | Product | Package Size | EFP | CP | SB | DC | Composition | Registr. Holder | Category | | | | |
|---|
|
| L | | IP | CI | PP | Jardiance Met 5 mg/500 mg | 60 Tablet(s) | 43.31 | 63.50 | 10 % | | Coated tablets: 2 Active Agents | Boehringer Ingelheim
(Schweiz) GmbH | B / SL | FB | | G |  |
| L | | IP | CI | PP | Jardiance Met 5 mg/500 mg | 180 Tablet(s) | 129.91 | 157.70 | 10 % | | Coated tablets: 2 Active Agents | Boehringer Ingelheim
(Schweiz) GmbH | B / SL | FB | | G | |
| L | | IP | CI | PP | Jardiance Met 5 mg/850 mg | 60 Tablet(s) | 43.31 | 63.50 | 10 % | | Coated tablets: 2 Active Agents | Boehringer Ingelheim
(Schweiz) GmbH | B / SL | FB | | G | |
| L | | IP | CI | PP | Jardiance Met 5 mg/850 mg | 180 Tablet(s) | 129.91 | 157.70 | 10 % | | Coated tablets: 2 Active Agents | Boehringer Ingelheim
(Schweiz) GmbH | B / SL | FB | | G | |
| L | | IP | CI | PP | Jardiance Met 5 mg/1000 mg | 60 Tablet(s) | 43.31 | 63.50 | 10 % | | Coated tablets: 2 Active Agents | Boehringer Ingelheim
(Schweiz) GmbH | B / SL | FB | | G | |
| L | | IP | CI | PP | Jardiance Met 5 mg/1000 mg | 180 Tablet(s) | 129.91 | 157.70 | 10 % | | Coated tablets: 2 Active Agents | Boehringer Ingelheim
(Schweiz) GmbH | B / SL | FB | | G | |
| | | IP | | PP | Jardiance Met 12.5 mg/500 mg | 60 | PR | PR | k.A. | | Coated tablets: 2 Active Agents | Boehringer Ingelheim
(Schweiz) GmbH | B | FB | | G | |
| | | IP | | PP | Jardiance Met 12.5 mg/500 mg | 180 | PR | PR | k.A. | | Coated tablets: 2 Active Agents | Boehringer Ingelheim
(Schweiz) GmbH | B | FB | | G | |
| | | IP | | PP | Jardiance Met 12.5 mg/850 mg | 60 | PR | PR | k.A. | | Coated tablets: 2 Active Agents | Boehringer Ingelheim
(Schweiz) GmbH | B | FB | | G | |
| | | IP | | PP | Jardiance Met 12.5 mg/850 mg | 180 | PR | PR | k.A. | | Coated tablets: 2 Active Agents | Boehringer Ingelheim
(Schweiz) GmbH | B | FB | | G | |
| | | IP | | PP | Jardiance Met 12.5
mg/1000 mg | 60 | PR | PR | k.A. | | Coated tablets: 2 Active Agents | Boehringer Ingelheim
(Schweiz) GmbH | B | FB | | G | |
| | | IP | | PP | Jardiance Met 12.5
mg/1000 mg | 180 | PR | PR | k.A. | | Coated tablets: 2 Active Agents | Boehringer Ingelheim
(Schweiz) GmbH | B | FB | | G | |
|
| L | | IP | CI | PP | Jardiance 10 mg | 30 Tablet(s) | 40.58 | 60.55 | 10 % | | Coated tablets: Empagliflozinum 10 mg | Boehringer Ingelheim
(Schweiz) GmbH | B / SL | FB | | G | |
| L | | IP | CI | PP | Jardiance 10 mg | 90 Tablet(s) | 121.84 | 148.90 | 10 % | | Coated tablets: Empagliflozinum 10 mg | Boehringer Ingelheim
(Schweiz) GmbH | B / SL | FB | | G | |
| | | IP | CI | PP | Jardiance 25 mg | 30 | PR | PR | k.A. | | Coated tablets: Empagliflozinum 25 mg | Boehringer Ingelheim
(Schweiz) GmbH | B | FB | | G | |
| | | IP | CI | PP | Jardiance 25 mg | 90 | PR | PR | k.A. | | Coated tablets: Empagliflozinum 25 mg | Boehringer Ingelheim
(Schweiz) GmbH | B | FB | | G | |
